Alkermes Plc

Alkermes Plc

ALKS · NASDAQ · Healthcare / Drug Manufacturers - Specialty & Generic

47.03USD+0.05 (+0.11%)

Price History

Full chart

Market Stats

Previous Close46.98
Open46.83
Day Range46.10 – 47.44
52-Week Range27.00 – 55.67
Volume1.43M
Market Cap6.85B
P/E (TTM)107.50
Forward P/E133.33
EPS0.38
Dividend Yield0.00%
Beta0.26
50-Day Avg48.35
200-Day Avg38.73

About

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Joshua Reed M.B.A.
  • Employees2.05K
  • HeadquartersConnaught House, Dublin, Ireland, D04 C5Y6, USA
  • Websitehttps://www.alkermes.com

Leadership

  • Mr. Joshua Reed M.B.A.Senior VP & CFO · b. 1973
  • Mr. David Joseph Gaffin J.D.Executive VP, Chief Legal Officer, Chief Compliance Officer & Secretary · b. 1972
  • Dr. Craig C. Hopkinson M.D.Executive VP of Research & Development and Chief Medical Officer · b. 1969
  • Mr. Christian Todd NicholsSenior VP & Chief Commercial Officer · b. 1970
  • Mr. Samuel J. ParisiInterim Principal Accounting Officer & VP of Finance · b. 1975
  • Mr. Tom SkoffSVP & Chief Information Officer
  • Ms. Sandra CoombsSenior Vice President of Corporate Affairs & Investor Relations
  • Mr. Stephen SchiavoSenior VP & Chief Human Resources Officer
  • Mr. Peter NormanSVP of Policy, Government & Community Relations
  • Mr. Declan O'ConnorSenior Vice President of Operations and Environment, Health & Safety

Financials

Income Statement

Currency: USD1991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue9.50M7.80M12.30M15.92M19.83M31.37M33.90M22.92M56.03M54.10M47.27M39.05M76.13M166.60M239.97M240.72M326.84M178.28M186.64M389.98M575.55M575.55M432.90M618.79M628.34M745.69M903.37M1.09B1.17B1.04B1.17B1.11B1.66B1.56B1.48B
Growth (%)--17.89%+57.69%+29.42%+24.55%+58.20%+8.08%-32.39%+144.45%-3.44%-12.63%-17.37%+94.92%+118.85%+44.04%+0.31%+35.78%-45.45%+4.69%+108.95%+47.59%0.00%-24.78%+42.94%+1.54%+18.68%+21.15%+21.13%+7.01%-11.29%+13.00%-5.28%+49.61%-6.36%-5.25%
Cost of Revenue15.20M-2.80M-2.20M-2.40M-2.40M--21.60M-6.43M-7.70M78.24M10.91M19.04M16.83M23.49M45.21M40.68M43.40M49.44M52.19M127.58M170.47M310.48M134.30M175.83M138.99M132.12M154.75M176.42M180.38M178.32M197.32M218.07M253.04M245.33M196.46M
Gross Profit-5.70M10.60M14.50M16.40M16.40M19.83M55.50M29.35M63.73M56.03M36.36M20.02M59.29M143.11M194.76M200.04M283.44M128.84M134.46M262.40M405.08M265.07M298.60M442.96M489.35M613.57M748.63M917.85M990.56M860.44M976.43M893.73M1.41B1.31B1.28B
Gross Margin-60.00%135.90%117.89%103.02%82.72%63.21%163.72%128.06%113.74%103.56%76.92%51.26%77.89%85.90%81.16%83.10%86.72%72.27%72.04%67.29%70.38%46.06%68.98%71.58%77.88%82.28%82.87%83.88%84.59%82.83%83.19%80.39%84.79%84.25%86.69%
Operating Expense36.60M29.20M26.30M29.10M33.82M30.78M100.90M105.29M93.63M118.41M118.58M116.92M132.67M129.45M183.71M202.83M148.49M171.88M180.09M350.68M323.27M183.26M283.10M530.10M713.65M822.24M896.53M1.02B1.17B972.87M878.68M899.82M996.25M891.66M1.03B
Operating Income-42.30M-18.60M-11.80M-12.70M-17.42M-10.95M-45.40M-75.93M-29.91M-62.38M-82.22M-96.90M-73.38M13.66M11.04M-2.79M134.96M-43.03M-45.63M-88.28M81.81M81.81M15.50M-87.14M-224.30M-208.66M-147.90M-99.13M-175.48M-112.43M97.75M-6.09M414.12M420.64M253.96M
Operating Margin-445.26%-238.46%-95.93%-79.80%-87.84%-34.92%-133.92%-331.29%-53.38%-115.30%-173.96%-248.12%-96.39%8.20%4.60%-1.16%41.29%-24.14%-24.45%-22.64%14.21%14.21%3.58%-14.08%-35.70%-27.98%-16.37%-9.06%-14.99%-10.82%8.33%-0.55%24.90%27.00%17.21%
EBITDA-40.80M-15.80M-9.60M-9.60M-14.85M-6.16M-23.80M-69.50M-22.21M-51.88M-66.40M-86.19M-51.23M24.54M23.03M15.77M155.03M-13.70M-34.54M-38.40M158.19M115.39M66.40M97.49M-125.16M-105.24M-32.74M-7.87M-103.04M-6.02M177.60M59.77M519.48M494.86M330.89M
EBITDA Margin-429.47%-202.56%-78.05%-60.32%-74.90%-19.64%-70.21%-303.24%-39.64%-95.89%-140.49%-220.71%-67.30%14.73%9.60%6.55%47.43%-7.69%-18.51%-9.85%27.48%20.05%15.34%15.75%-19.92%-14.11%-3.62%-0.72%-8.80%-0.58%15.13%5.38%31.23%31.77%22.42%
Net Income-40.10M-17.30M-11.90M-13.75M-18.80M-12.58M-41.10M-68.05M-16.87M-61.35M-106.90M-102.38M-75.17M3.82M9.45M166.98M130.50M-39.63M-45.54M-113.68M24.98M24.98M17.60M-30.06M-227.16M-208.44M-157.94M-139.31M-196.62M-110.86M-48.17M-158.27M355.76M367.07M241.66M
Net Income Margin-422.11%-221.79%-96.75%-86.36%-94.81%-40.11%-121.24%-296.89%-30.11%-113.41%-226.16%-262.16%-98.74%2.29%3.94%69.37%39.93%-22.23%-24.40%-29.15%4.34%4.34%4.07%-4.86%-36.15%-27.95%-17.48%-12.73%-16.79%-10.67%-4.10%-14.24%21.39%23.57%16.37%
R&D-20.50M19.00M21.59M29.55M31.76M48.50M54.48M68.77M92.09M85.39M91.10M91.64M89.07M117.31M125.27M89.48M95.36M97.24M141.89M140.01M6.54M128.10M272.04M344.40M387.15M412.89M425.41M512.83M394.59M290.92M272.70M270.81M245.33M323.96M
R&D as % of Total Revenue-262.82%154.47%135.60%149.06%101.26%143.07%237.70%122.74%170.22%180.65%233.26%120.38%53.46%48.89%52.04%27.38%53.49%52.10%36.38%24.33%1.14%29.59%43.96%54.81%51.92%45.71%38.88%43.80%37.99%24.79%24.53%16.28%15.75%21.95%
Interest Expense8.10M40.10M17.30M11.90M13.70M18.80M9.77M41.06M68.05M13.04M1.02M31.17M102.38M73.92M3.82M499.00K13.76M5.97M3.30M28.11M48.99M48.99M013.43M13.25M14.89M12.01M15.44M13.60M8.66M11.22M13.04M23.03M22.58M12.28M
Interest Expense % of Total Revenue85.26%514.10%140.65%74.76%69.10%59.93%28.82%179.13%121.45%24.10%2.16%79.82%134.49%44.37%1.59%0.21%4.21%3.35%1.77%7.21%8.51%8.51%0.00%2.17%2.11%2.00%1.33%1.41%1.16%0.83%0.96%1.17%1.38%1.45%0.83%

Balance Sheet

Currency: USD1991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets55.70M54.00M46.30M36.70M57.61M104.70M220.52M213.04M403.62M386.32M291.14M296.67M201.81M338.87M563.38M730.48M656.31M519.90M515.60M452.45M1.44B1.47B1.58B1.92B1.86B1.73B1.80B1.83B1.81B1.95B2.02B1.96B2.14B2.06B2.53B
Total Liabilities1.50M6.30M14.40M15.50M24.12M25.55M53.83M50.20M242.25M265.18M232.78M197.85M182.97M334.76M371.14M345.84M351.00M100.67M102.98M60.43M581.37M517.92M512.40M524.43M541.47M516.94M594.42M653.72M719.96M882.75M911.90M920.23M933.54M590.59M710.96M
Total Equity54.20M47.70M31.90M21.20M33.49M79.15M166.69M162.85M161.37M121.14M58.35M98.82M18.84M4.11M192.24M384.65M305.31M419.23M412.62M392.02M853.85M952.37M1.07B1.40B1.31B1.21B1.20B1.17B1.09B1.07B1.11B1.04B1.20B1.46B1.82B
Cash3.10M300.00K2.70M1.10M210.78K2.80M16.12M4.78M4.27M6.77M109.91M11.95M35.72M47.48M83.22M320.93M101.24M73.93M79.32M38.39M83.60M96.96M167.60M224.06M181.11M186.38M191.30M266.76M203.77M272.96M337.54M292.47M457.47M291.15M1.12B
Total Debt300.00K2.90M9.00M11.10M15.45M14.46M38.17M33.72M224.14M237.93M175.04M122.49M129.17M277.87M158.62M160.08M160.37M57.30M51.04M444.46M444.46M369.01M364.30M357.97M349.94M283.67M281.44M279.31M290.95M410.16M416.21M379.44M372.19M75.54M70.00M
Net Debt-2.80M2.60M6.30M10.00M15.24M11.66M22.05M28.94M219.87M231.15M65.13M110.54M93.45M230.39M75.39M-160.85M59.13M-16.63M-28.28M-38.39M360.86M272.05M196.70M133.91M168.84M97.29M90.14M12.55M87.17M137.20M78.66M86.96M-85.28M-215.61M-1.05B

Cash Flow

Currency: USD1991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-45.20M-6.00M-12.30M-9.10M-5.50M-17.18M-1.14M-14.25M-33.03M-17.99M-42.68M-48.75M-98.25M-74.25M116.53M83.73M42.42M34.59M-12.25M-5.91M-2.48M126.55M92.20M11.14M-40.36M-63.80M19.19M99.28M72.08M82.84M101.72M21.04M401.35M439.12M520.75M
Investing Cash Flow-8.90M1.60M8.30M5.40M-11.90M-56.80M-113.05M4.54M-194.51M21.19M42.07M31.80M-80.88M-38.78M-137.87M-30.08M61.97M45.36M28.01M5.63M-417.16M-68.15M-177.19M-263.40M-43.49M127.24M-18.36M-22.20M-141.83M-11.48M-66.20M-64.54M53.36M-111.31M295.50M
Financing Cash Flow57.20M1.50M6.30M2.10M16.80M76.31M114.87M15.16M224.54M-3.30M10.74M73.37M116.60M150.62M7.43M-6.73M-83.65M-94.30M-23.33M-40.65M464.85M-45.04M43.70M308.76M40.89M-58.17M4.08M-1.62M6.76M-2.17M29.07M-1.57M-289.71M-494.14M12.38M
Capital Expenditure800.00K2.50M1.90M600.00K5.60M2.24M7.99M24.06M5.76M10.02M33.38M46.27M15.10M17.82M28.66M36.30M21.89M5.50M15.79M9.40M16.99M22.22M19.05M33.65M52.88M43.66M51.30M69.43M90.94M42.22M29.02M38.26M48.05M33.48M40.42M
Free Cash Flow-46.00M-8.50M-14.20M-9.70M-11.10M-19.42M-9.13M-38.31M-38.79M-28.01M-76.07M-95.02M-113.35M-92.07M87.87M47.42M20.53M29.09M-28.03M-15.31M-19.47M104.33M73.10M-22.51M-93.24M-107.46M-32.11M29.85M-18.86M40.62M72.69M-17.21M353.31M405.64M480.33M
Dividends Paid-------7.45M9.22M7.27M----------00-0000-9.61M672.00K8.75M1.43M---
FCF to OCF101.77%141.67%115.45%106.59%201.82%113.06%803.30%268.88%117.43%155.70%178.22%194.92%115.37%123.99%75.41%56.64%48.40%84.09%228.91%259.18%784.45%82.44%79.28%-202.10%231.01%168.43%-167.33%30.07%-26.17%49.04%71.47%-81.79%88.03%92.37%92.24%
Dividend Paid to FCF--------19.46%-23.78%-25.95%----------0.00%0.00%-0.00%0.00%0.00%0.00%--50.93%1.65%12.03%-8.29%---

Earnings

Report DateFeb 14, 1996Jun 21, 1996Aug 12, 1996Nov 8, 1996Jan 17, 1997May 23, 1997Aug 8, 1997Nov 11, 1997Feb 11, 1998Jun 5, 1998Jun 30, 1998Oct 7, 1998Feb 12, 1999Jun 24, 1999Aug 16, 1999Nov 15, 1999Feb 14, 2000Jun 28, 2000Aug 14, 2000Nov 13, 2000Feb 13, 2001May 23, 2001Aug 14, 2001Nov 8, 2001Feb 14, 2002Jun 27, 2002Aug 14, 2002Nov 7, 2002Feb 12, 2003May 29, 2003Aug 7, 2003Nov 5, 2003Feb 11, 2004May 13, 2004Aug 5, 2004Nov 4, 2004Feb 3, 2005May 19, 2005Aug 4, 2005Nov 3, 2005Feb 7, 2006May 18, 2006Aug 8, 2006Nov 2, 2006Feb 7, 2007May 29, 2007Aug 2, 2007Nov 1, 2007Feb 7, 2008May 22, 2008Aug 7, 2008Nov 6, 2008Feb 5, 2009May 21, 2009Aug 6, 2009Nov 5, 2009Feb 4, 2010May 13, 2010Aug 5, 2010Nov 4, 2010Feb 3, 2011May 18, 2011Aug 1, 2011Nov 3, 2011Feb 2, 2012May 17, 2012Jul 26, 2012Nov 1, 2012Jan 31, 2013May 23, 2013Jul 25, 2013Oct 31, 2013Feb 27, 2014Apr 30, 2014Jul 31, 2014Oct 29, 2014Feb 24, 2015Apr 30, 2015Jul 30, 2015Oct 29, 2015Feb 25, 2016Apr 28, 2016Jul 28, 2016Nov 2, 2016Feb 15, 2017Apr 27, 2017Jul 27, 2017Oct 26, 2017Feb 14, 2018Apr 26, 2018Jul 26, 2018Oct 23, 2018Feb 14, 2019Apr 25, 2019Jul 25, 2019Oct 23, 2019Feb 13, 2020Apr 29, 2020Jul 29, 2020Oct 29, 2020Feb 11, 2021Apr 28, 2021Jul 28, 2021Oct 27, 2021Feb 16, 2022Apr 27, 2022Jul 27, 2022Nov 2, 2022Feb 16, 2023Apr 26, 2023Jul 26, 2023Oct 25, 2023Feb 15, 2024May 1, 2024Jul 24, 2024Oct 24, 2024Feb 12, 2025May 1, 2025Jul 29, 2025Oct 28, 2025Feb 25, 2026May 5, 2026Jul 28, 2026Oct 27, 2026
EPS Estimate-0.12-0.14-0.15-0.14-0.14-0.15-0.12-0.11-0.10-0.12--0.10-0.15-0.27-0.27-0.30-0.28-0.32-0.11-0.34-0.35-0.41-0.23-0.25-0.31-0.31-0.35-0.25-0.32-0.32-0.31-0.22-0.26-0.16-0.20-0.20-0.14-0.17-0.18-0.11-0.07-0.02-0.010.01-0.010.040.04-0.010.020.20-0.020.28-0.12-0.08-0.10-0.15-0.12-0.14-0.14-0.15-0.14-0.11-0.08-0.10-0.150.160.100.230.170.220.220.200.100.140.020.04-0.05-0.10-0.21-0.18-0.20-0.10-0.040.04-0.09-0.01-0.010.23-0.090.13-0.08-0.04-0.17-0.12-0.210.66-0.06-0.010.000.07-0.020.120.100.080.030.050.030.05-0.010.640.430.510.580.710.710.760.240.400.390.41-0.04-0.04-0.08
EPS Actual-0.08-0.18-0.14-0.13-0.11-0.12-0.09-0.02-0.07-0.04-0.16-0.09-0.09-0.30-0.20-0.33-0.38-0.590.13-0.19-0.17-0.22-0.13-0.20-0.17-0.35-0.33-0.13-0.20-0.30-0.44-0.31-0.23-0.27-0.29-0.16-0.10-0.18-0.150.120.020.040.070.100.030.030.080.07-0.02-0.190.310.02-0.09-0.14-0.02-0.09-0.07-0.13-0.14-0.06-0.12-0.14-0.14-0.22-0.11-0.130.340.170.340.400.300.220.270.110.110.030.110.06-0.09-0.18-0.15-0.16-0.01-0.090.15-0.180.010.030.31-0.090.290.070.34-0.170.09-0.040.830.010.060.260.100.110.300.140.230.120.060.020.140.010.550.640.220.430.700.731.050.290.680.650.290.380.52-
Surprise33.33%-28.57%6.67%7.14%21.43%20.00%25.00%81.82%30.00%66.67%-10.00%40.00%-11.11%25.93%-10.00%-35.71%-84.38%218.18%44.12%51.43%46.34%43.48%20.00%45.16%-12.90%5.71%48.00%37.50%6.25%-41.94%-40.91%11.54%-68.75%-45.00%20.00%28.57%-5.88%16.67%209.09%128.57%300.00%800.00%900.00%-200.00%100.00%75.00%-100.00%-1037.00%55.00%200.00%-132.14%-16.67%75.00%10.00%53.33%-8.33%0.00%57.14%20.00%0.00%-27.27%-175.00%-10.00%13.33%112.50%70.00%47.83%135.29%36.36%0.00%35.00%10.00%-21.43%50.00%175.00%220.00%10.00%14.29%16.67%20.00%90.00%-125.00%275.00%-100.00%200.00%400.00%34.78%0.00%123.08%187.50%950.00%0.00%175.00%80.95%25.76%116.67%700.00%12900.00%42.86%650.00%150.00%40.00%187.50%300.00%20.00%-33.33%180.00%200.00%-14.06%48.84%-56.86%-25.86%-1.41%2.82%38.16%20.83%70.00%66.67%-29.27%1050.00%1400.00%-
Timing------Pre-marketPre-market-------------After-hoursPre-market-Pre-market-After-hoursPre-marketAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursPre-marketPre-market-Pre-market---Pre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-

Key Statistics & Ratios

Market Cap6.85B
Enterprise Value7.98B
Trailing P/E107.50
Forward P/E133.33
PEG Ratio1.96
Price / Sales4.11
Price / Book3.91
EPS0.38
Book Value10.80
Revenue (TTM)1.67B
Gross Profit (TTM)1.45B
EBITDA284.93M
Profit Margin3.97%
Operating Margin15.50%
Return on Equity3.85%
Return on Assets4.20%
Shares Outstanding167.76M
Shares Float155.19M
Beta0.26
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 15 analystsTarget 56.56
  • Strong Buy
    8
  • Buy
    1
  • Hold
    6

Ownership Breakdown

Institutions
107.86%
Insiders
1.40%
Retail / Other
0.00%

Top Institutional Holders

  • BlackRock Inc
    28.31M16.88%
  • Baker Bros Advisors LP
    10.01M5.97%
  • Vanguard Portfolio Management, LLC
    9.51M5.67%
  • State Street Corp
    9.47M5.64%
  • Vanguard Capital Management, LLC
    7.43M4.43%
  • Renaissance Technologies Corp
    6.16M3.67%
  • T. Rowe Price Associates, Inc.
    4.66M2.78%
  • COMMODORE CAPITAL LP
    4.20M2.50%
  • Dimensional Fund Advisors, Inc.
    4.19M2.50%
  • Geode Capital Management, LLC
    4.18M2.49%
  • JPMorgan Chase & Co
    4.10M2.44%
  • Deep Track Capital, LP
    4.00M2.38%
  • American Century Companies Inc
    3.95M2.36%
  • Wellington Management Company LLP
    2.81M1.68%
  • PRIMECAP Management Company
    2.53M1.51%
  • Nuveen, LLC
    2.46M1.47%

Top Fund Holders

  • iShares Core S&P Small-Cap ETF
    10.16M6.06%
  • Vanguard MStar Total Stk Mkt Idx Invest
    5.31M3.16%
  • iShares Russell 2000 ETF
    4.27M2.55%
  • Vanguard Small Cap Index
    3.84M2.29%

Stock Splits

  • May 15, 20002:1